Pages that link to "Q24685541"
Jump to navigation
Jump to search
The following pages link to Characterization of gene expression induced by RET with MEN2A or MEN2B mutation (Q24685541):
Displaying 29 items.
- Failure to recognize multiple endocrine neoplasia 2B: more common than we think? (Q28254996) (← links)
- Cancer phenomics: RET and PTEN as illustrative models (Q28278854) (← links)
- Identification of a Novel Glial Cell Line-derived Neurotrophic Factor-inducible Gene Required for Renal Branching Morphogenesis (Q28594597) (← links)
- Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer (Q33439045) (← links)
- Influence of RET/PTC1 and RET/PTC3 oncoproteins in radiation-induced papillary thyroid carcinomas on amounts of cytoskeletal protein species (Q33691784) (← links)
- Actin depolymerizing factors cofilin1 and destrin are required for ureteric bud branching morphogenesis. (Q33741934) (← links)
- Anti-proliferative effect and action mechanism of dexamethasone in human medullary thyroid cancer cell line (Q34040494) (← links)
- RET PLCγ phosphotyrosine binding domain regulates Ca2+ signaling and neocortical neuronal migration. (Q34166301) (← links)
- Stanniocalcin1 (STC1) Inhibits Cell Proliferation and Invasion of Cervical Cancer Cells (Q34575305) (← links)
- Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization (Q34809183) (← links)
- Regulation of microRNA expression by HMGA1 proteins (Q34929852) (← links)
- Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma (Q35808203) (← links)
- RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease. (Q36458528) (← links)
- Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patients (Q36537642) (← links)
- Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis (Q37455527) (← links)
- Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations. (Q37633558) (← links)
- Lysyl oxidase: a potential target for cancer therapy (Q37812321) (← links)
- How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer (Q37902072) (← links)
- Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display (Q38329273) (← links)
- RET-mediated gene expression pattern is affected by isoform but not oncogenic mutation. (Q38510959) (← links)
- Advances in understanding functional variations in the Hirschsprung disease spectrum (variant Hirschsprung disease). (Q39042354) (← links)
- Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice (Q39973725) (← links)
- RET and neuroendocrine tumors (Q40221010) (← links)
- Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. (Q40277135) (← links)
- Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma. (Q40524527) (← links)
- Identification of human SEP1 as a glial cell line-derived neurotrophic factor-inducible protein and its expression in the nervous system (Q40622577) (← links)
- Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis (Q42796164) (← links)
- Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties (Q42824227) (← links)
- Cell signalling and gene expression mediated by RET tyrosine kinase (Q44446966) (← links)